The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review

被引：17

作者：

Clark, Joshua J. ^{[1
]}

Secrest, Aaron M. ^{[1
]}

Hull, Christopher M. ^{[1
]}

Eliason, Mark J. ^{[1
]}

Leiferman, Kristin M. ^{[1
]}

Gleich, Gerald J. ^{[1
]}

Powell, Douglas L. ^{[1
]}

机构：

[1] Univ Utah, Dept Dermatol, 30 North 1900 East,4A330, Salt Lake City, UT 84132 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2015.12.052

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1274 / 1276

页数：4

共 5 条

[1] Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review [J].

Carrillo, Diana C. ;

Sanchez Borges, Mario ;

Garcia, Elizabeth ;

Egea, Eduardo ;

Serrano, Carlos D. .

WORLD ALLERGY ORGANIZATION JOURNAL, 2014, 7

[2]

Genentech I, 2014, XOLAIR OMALIZUMAB SU, P1

[3] Treatment of chronic autoimmune urticaria with omalizumab [J].

Kaplan, Allen P. ;

Joseph, Kusumam ;

Maykut, Robert J. ;

Geba, Gregory P. ;

Zeldin, Robert K. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573

[4]

ODonnell BF, 1997, BRIT J DERMATOL, V136, P197

[5] An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualized [J].

Uysal, Pinar ;

Eller, Esben ;

Mortz, Charlotte G. ;

Bindslev-Jensen, Carsten .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (03) :914-+

← 1 →